A doctor reveals why three cutting-edge medical innovations may leave patients with more questions and concerns than answers.

A new investigational treatment for certain folks with colorectal or appendix cancer.

When Sarah Beran’s symptoms first appeared, she thought it was probably IBS or fatigue from being a young, busy mom. Beran, ...

Scientists have identified a biological chain reaction that may help explain why some people with colorectal cancer lose ...

The Penn spinout launched a year ago with CAR-T pioneer Carl June as a scientific co-founder and $216 million in funding from ...

NEST Pushes Neoadjuvant Immunotherapy Forward in Colon Cancer / Alana Nguyen, Alessio Pigazzi, Allyson Ocean, Balstilimab, ...

Neoadjuvant BOT/BAL in Localized Colon Cancer / BOT/BAL, botensilimab, botensilimab and baltilimab, cancer, cancer care, ...

This year’s successful projects span children and young people’s supportive care, new diagnostic tests, digital patient ...

The Food and Drug Administration’s approval on Wednesday of a new drug for pancreatic cancer marked the end of a long quest ...

Dr. Ian Grant, behavioral neurologist at Northwestern Medicine’s Cognitive Neurology & Alzheimer’s Disease Center, joins Bob ...

(Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the peer-reviewed publication of updated results from the investigator-sponsored Phase 2 NEST trial evaluating neoadjuvant ...

They could also hold clues to developing new cancer treatments. According to a study from the journal Gut Microbes, certain ...